TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer immunology research

• Publication date

  2015-02-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2326-6066.CIR-14-0232PMID 25716473PMCID PMC4420686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Arginase I in Myeloid Cells Limits Control of Residual Disease after Radiation Therapy of Tumors in Mice

  2014cited by this paper
• Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

  2014cited by this paper
• IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways.

  2014cited by this paper
• Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

  2014cited by this paper
• B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.

  2014cited by this paper
• Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

  2014cited by this paper
• CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

  2013cited by this paper
• Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.

  2013cited by this paper
• CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells

  2013cited by this paper
• Combining radiotherapy and cancer immunotherapy: a paradigm shift.

  2013cited by this paper
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression

  2013cited by this paper
• Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

  2013cited by this paper
• Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation

  2012influential reference
• Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy

  2012cited by this paper
• Defining care provided for breast cancer based on medical record review or Medicare claims: information from the Centers for Disease Control and Prevention Patterns of Care Study.

  2012cited by this paper
• Differential macrophage programming in the tumor microenvironment.

  2012cited by this paper
• Global burden of cancer: opportunities for prevention.

  2012cited by this paper
• Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

  2011influential reference
• Leukocyte composition of human breast cancer

  2011cited by this paper
• Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome

  2011cited by this paper
• CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis

  2011cited by this paper
• Immune microenvironments in solid tumors: new targets for therapy.

  2011cited by this paper
• Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

  2011cited by this paper
• Circulating and tumor‐infiltrating myeloid cells predict survival in human pleural mesothelioma

  2011cited by this paper
• Pharmacodynamic activity demonstrated in phase I for PLX3397, a selective inhibitor of FMS and Kit.

  2011cited by this paper
• The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

  2010cited by this paper
• The Tumor-Immune Microenvironment and Response to Radiation Therapy

  2010cited by this paper
• Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

  2010cited by this paper
• IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

  2010cited by this paper
• Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.

  2010cited by this paper
• Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ

  2010cited by this paper
• CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

  2009cited by this paper
• Trophic macrophages in development and disease

  2009cited by this paper
• The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma

  2009cited by this paper
• Untangling the Complex Web of IL-4– and IL-13–Mediated Signaling Pathways

  2008cited by this paper
• Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor1

  2005cited by this paper
• CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis

  2004cited by this paper
• The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

  2002cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity1

  2001cited by this paper
• Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

  1992cited by this paper
• M‐CSF (monocyte colony stimulating factor) and M‐CSF receptor expression by breast tumour cells: M‐CSF mediated recruitment of tumour infiltrating monocytes?

  1992influential reference

• Screening and mechanistic investigation of key radioresistance genes in oral squamous cell carcinoma

  2026cites this paper
• Molecular and cellular remodeling of the colorectal tumor microenvironment using nanoparticles

  2026cites this paper
• Mechanisms of radioresistance and radiosensitization strategies for Triple Negative Breast Cancer

  2025cites this paper
• Field cancerization, accelerated aging, and immunosuppression: the rapid rise of hormone-sensitive and early-onset breast cancer

  2025cites this paper
• Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy

  2025cites this paper
• Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories.

  2025cites this paper
• Radiation therapy causes a STING and MyD88-independent upregulation of CD80 and CD86 in macrophages and monocytes that limits tumor control

  2025cites this paper
• Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

  2025cites this paper
• Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics

  2025cites this paper
• IL-1 family members as regulators of lymphoid type-2 immunity in cancer.

  2025cites this paper
• Facts and hopes in radioimmunotherapy for localized stages of cancer.

  2025cites this paper
• Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth.

  2025cites this paper
• Recognition of pivotal immune genes NR1H4 and IL4R as diagnostic biomarkers in distinguishing ovarian clear cell cancer from high-grade serous cancer

  2025cites this paper
• Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors.

  2025cites this paper
• Genome-wide transcriptomic response of whole blood to radiation

  2025cites this paper
• Fungal Colonization by Malassezia globosa Promotes Breast Cancer Progression and M2 Macrophage Polarization Through the MBL‐C3a–C3aR Signaling Pathway

  2025cites this paper
• Towards a personalized utilization of stereotactic body radiotherapy for the management of liver metastases in solid tumors

  2025cites this paper
• Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy

  2025cites this paper
• Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

  2025cites this paper
• The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration

  2024cites this paper
• Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.

  2024cites this paper
• Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology

  2024cites this paper
• Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment

  2024cites this paper
• IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis

  2024cites this paper
• Fungal footprints in oral cancer: unveiling the oral mycobiome

  2024cites this paper
• Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment.

  2024cites this paper
• Analysis of tumor microenvironment alterations in partially responsive rectal cancer patients treated with neoadjuvant chemoradiotherapy

  2024cites this paper
• Platelet Membrane Coated Cu9S8-SNAP for Targeting NIR-II Mild Photothermal Enhanced Chemodynamic/Gas Therapy of Triple-Negative Breast Cancer.

  2024cites this paper
• Dawn era for revisited cancer therapy by innate immune system and immune checkpoint inhibitors.

  2024cites this paper
• PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer

  2024cites this paper
• Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization

  2024cites this paper
• Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization

  2024cites this paper
• Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer.

  2024cites this paper
• Decoding long non-coding RNAs: Friends and foes in cancer development (Review)

  2024cites this paper
• Radiotherapy, immunity, and immune checkpoint inhibitors.

  2024cites this paper
• Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation

  2024cites this paper
• Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion

  2024cites this paper
• Senescent cell-derived extracellular vesicles inhibit cancer recurrence by coordinating immune surveillance

  2024cites this paper
• Harnessing innate immune pathways for therapeutic advancement in cancer

  2024cites this paper
• Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy

  2024cites this paper
• Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention

  2024cites this paper
• Mechanistic studies of tumor-associated macrophage immunotherapy

  2024influential citation
• Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities

  2024cites this paper
• Do macrophages follow the beat of circadian rhythm in TIME (Tumor Immune Microenvironment)?

  2023cites this paper
• Optimizing the manufacturing and antitumour response of CAR T therapy

  2023cites this paper
• Knowledge landscape of tumor-associated macrophage research: A bibliometric and visual analysis

  2023cites this paper
• Interaction of tumor-associated macrophages with stromal and immune components in solid tumors: Research progress (Review)

  2023cites this paper
• A timeline of tumour-associated macrophage biology

  2023cites this paper
• Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer

  2023cites this paper
• BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model

  2023cites this paper
• Extracellular matrix scaffold-assisted tumor vaccines induce tumor regression and long-term immune memory

  2023cites this paper
• The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer.

  2023cites this paper
• Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer

  2023cites this paper
• The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer

  2023cites this paper
• Effect of tumor-associated macrophages on the pyroptosis of breast cancer tumor cells

  2023cites this paper
• Roles of macrophages in tumor development: a spatiotemporal perspective

  2023cites this paper
• Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review

  2023cites this paper
• Radiation-induced tumor immune microenvironments and potential targets for combination therapy

  2023cites this paper
• Targeting oral tumor microenvironment for effective therapy

  2023cites this paper
• Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting.

  2023cites this paper
• The strange Microenvironment of Glioblastoma.

  2023cites this paper
• Selective COX-2 Inhibitor Etoricoxib’s Liposomal Formulation Attenuates M2 Polarization of TAMs and Enhances its Anti-metastatic Potential

  2023cites this paper
• Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction

  2023cites this paper
• Macrophage-reprograming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer.

  2023cites this paper
• Tumor hijacks macrophages and microbiota through extracellular vesicles

  2022cites this paper
• Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.

  2022cites this paper
• Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer

  2022cites this paper
• Innate immune responses in patients treated with SBRT irradiation enhances prostate cancer remissions

  2022cites this paper
• The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

  2022cites this paper
• Metabolism in tumor-associated macrophages.

  2022cites this paper
• Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor.

  2022cites this paper
• The Lymphatic Endothelium in the Context of Radioimmuno-Oncology

  2022cites this paper
• Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers

  2022cites this paper
• Human monocytes differentiate into tumor-associated macrophages upon SKOV3 cells coculture and/or lysophosphatidic acid stimulation

  2022cites this paper
• High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast Cancer

  2022cites this paper
• Polysaccharides of Brassica rapa L. attenuate tumor growth via shifting macrophages to M1‐like phenotype

  2022cites this paper
• Metastasis Role of myeloid cells in the tumor microenvironment

  2022cites this paper
• Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus

  2022cites this paper
• Tumor-Mediated Neutrophil Polarization and Therapeutic Implications

  2022cites this paper
• Role of macrophages in tumor progression and therapy (Review)

  2022cites this paper
• The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis

  2022cites this paper
• The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes

  2022cites this paper
• Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice

  2021cites this paper
• Targeting Innate Immunity in Cancer Therapy

  2021cites this paper
• Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer

  2021cites this paper
• Tumor associated macrophage and microbe: the potential targets of tumor vaccine delivery.

  2021cites this paper
• LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis

  2021cites this paper
• Next frontier in tumor immunotherapy: macrophage-mediated immune evasion

  2021cites this paper
• Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity

  2021cites this paper
• Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives

  2021cites this paper
• M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.

  2021cites this paper
• TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling

  2021cites this paper
• Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer

  2021cites this paper
• Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.

  2021cites this paper
• Low-dose JAK3-inhibition improves anti-tumor T-cell immunity and immunotherapy efficacy.

  2021cites this paper
• Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

  2021cites this paper
• Tumor Associated Macrophages and TAMs‐Based Anti‐Tumor Nanomedicines

  2021cites this paper
• Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment

  2021cites this paper
• Tumor-Associated Macrophages: A Potential Target for Cancer Therapy

  2021cites this paper
• Tumor-Associated Macrophages: Combination of Therapies, the Approach to Improve Cancer Treatment

  2021cites this paper